Core Scientific Closes $3.3 Billion Senior Secured Notes Offering to Fund Strategic Expansion and Refinance Debt
CORZ has more than doubled off its 52-week low of $8.47 on elevated volume (3.0× avg).
Summary
Core Scientific's subsidiary completed a $3.3 billion senior secured notes offering, generating $3.24 billion in net proceeds to fund a debt service reserve, repay a $1 billion bridge facility, and support strategic growth initiatives.
Key Events · Financing and Capital Events · CORZ
-
Notes Offering Closed
Core Scientific Finance I LLC, a wholly-owned indirect subsidiary, completed a private offering of $3.3 billion in 7.750% Senior Secured Notes due 2031. The notes were issued at 99.250% of their principal amount.
-
Net Proceeds Generated
The offering generated approximately $3.24 billion in net proceeds for the company.
-
Debt Refinancing
A portion of the net proceeds will be used to repay in full the outstanding $1 billion delayed-draw bridge credit facility, consolidating debt.
-
Strategic Funding for Growth
Remaining proceeds will fund a debt service reserve account and be distributed to Core Scientific for general corporate purposes, supporting its strategic expansion into AI infrastructure and recent acquisitions.
Analysis · CORZ · Crypto Assets
This filing marks the successful closing of a substantial $3.3 billion senior secured notes offering, a critical financing event for Core Scientific. The net proceeds of approximately $3.24 billion will significantly bolster the company's financial position, enabling it to fund a debt service reserve and fully repay its outstanding $1 billion delayed-draw bridge credit facility. This capital infusion is crucial for supporting the company's recently announced strategic expansion into AI infrastructure and the acquisition of Polaris DS LLC, as seen in recent filings. The 7.750% interest rate and 2031 maturity provide long-term financing, while the parent company's completion guarantee for key projects enhances the credit profile of the notes. This move provides necessary liquidity and financial stability for Core Scientific's ambitious growth plans.
At the time of this filing, CORZ was trading at $22.40 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $7.8B. The 52-week trading range was $8.47 to $25.01. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.